Form 4: Biogen Director Jesus B. Mantas Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Jesus B. Mantas reports changes in beneficial ownership of Biogen Inc. common stock, including acquisition and disposal of shares on June 21, 2024.
Summary
- On June 21, 2024, Jesus B. Mantas, a director of Biogen Inc., engaged in transactions involving the company's common stock.
- Mantas acquired 1,340 shares of common stock.
- Mantas also disposed of 7,388 shares of common stock.
- Following these transactions, Mantas directly owns 7,388 shares of Biogen Inc.
Sentiment
Score: 5
Explanation: This is a standard regulatory filing reflecting insider trading activity. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- Shareholders are informed about the trading activities of a Biogen Inc. director.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of stock acquisition and disposal transactions. |
| 06/25/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.